355 related articles for article (PubMed ID: 21826667)
1. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy.
Morales MG; Cabello-Verrugio C; Santander C; Cabrera D; Goldschmeding R; Brandan E
J Pathol; 2011 Dec; 225(4):490-501. PubMed ID: 21826667
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
[TBL] [Abstract][Full Text] [Related]
3. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
4. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy.
Desguerre I; Arnold L; Vignaud A; Cuvellier S; Yacoub-Youssef H; Gherardi RK; Chelly J; Chretien F; Mounier R; Ferry A; Chazaud B
Muscle Nerve; 2012 Jun; 45(6):803-14. PubMed ID: 22581532
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Pathological Activities of CCN2/CTGF in Muscle Dystrophy.
Acuña MJ; Brandan E
Methods Mol Biol; 2017; 1489():513-521. PubMed ID: 27734402
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.
Cabello-Verrugio C; Morales MG; Cabrera D; Vio CP; Brandan E
J Cell Mol Med; 2012 Apr; 16(4):752-64. PubMed ID: 21645240
[TBL] [Abstract][Full Text] [Related]
7. Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells.
Cabello-Verrugio C; Acuña MJ; Morales MG; Becerra A; Simon F; Brandan E
Biochem Biophys Res Commun; 2011 Jul; 410(3):665-70. PubMed ID: 21693104
[TBL] [Abstract][Full Text] [Related]
8. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy.
Sun G; Haginoya K; Wu Y; Chiba Y; Nakanishi T; Onuma A; Sato Y; Takigawa M; Iinuma K; Tsuchiya S
J Neurol Sci; 2008 Apr; 267(1-2):48-56. PubMed ID: 17996907
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation.
Vial C; Zúñiga LM; Cabello-Verrugio C; Cañón P; Fadic R; Brandan E
J Cell Physiol; 2008 May; 215(2):410-21. PubMed ID: 18064627
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
13. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases.
Gonzalez D; Brandan E
Mol Neurobiol; 2019 Aug; 56(8):5911-5916. PubMed ID: 30689195
[TBL] [Abstract][Full Text] [Related]
14. Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
Rebolledo DL; González D; Faundez-Contreras J; Contreras O; Vio CP; Murphy-Ullrich JE; Lipson KE; Brandan E
Matrix Biol; 2019 Sep; 82():20-37. PubMed ID: 30716392
[TBL] [Abstract][Full Text] [Related]
15. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.
Iwata Y; Katanosaka Y; Arai Y; Shigekawa M; Wakabayashi S
Hum Mol Genet; 2009 Mar; 18(5):824-34. PubMed ID: 19050039
[TBL] [Abstract][Full Text] [Related]
16. Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.
Riquelme-Guzmán C; Contreras O; Brandan E
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C415-C427. PubMed ID: 29351412
[TBL] [Abstract][Full Text] [Related]
17. Full-length dystrophin gene transfer to the mdx mouse in utero.
Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.
D'Antona G; Brocca L; Pansarasa O; Rinaldi C; Tupler R; Bottinelli R
J Physiol; 2007 Nov; 584(Pt 3):997-1009. PubMed ID: 17855756
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle.
Uezumi A; Ito T; Morikawa D; Shimizu N; Yoneda T; Segawa M; Yamaguchi M; Ogawa R; Matev MM; Miyagoe-Suzuki Y; Takeda S; Tsujikawa K; Tsuchida K; Yamamoto H; Fukada S
J Cell Sci; 2011 Nov; 124(Pt 21):3654-64. PubMed ID: 22045730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
